[1]
2009. Activity of Belinostat in patients with recurrent or refractory peripheral or cutaneous T-cell lymphoma. Hematology Meeting Reports (formerly Haematologica Reports). 3, 1 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v3i1.527.